Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Vipshop Holdings Ltd - ADR — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Vipshop Holdings Ltd - ADR trades at $12.87 (market cap $6.12B). The key difference: Vipshop Holdings Ltd - ADR is the larger of the two by market cap, and Vipshop Holdings Ltd - ADR pays a 4.81% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Vipshop Holdings Ltd - ADR for 50 Days on average.
| ORKA | VIPS | |
|---|---|---|
Market Cap | $5.18B | $6.12B |
Volume | 490,798 | 2,098,592 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $20.29 |
52-Week Low | $26.19 | $12.09 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $4.31B | $2.94B |
Dividend Yield | — | 4.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vipshop Holdings (VIPS) trades at $12.86, showing no change in the last session. The stock presents a compelling valuation with a P/E of 4.15 and P/S of 0.41, significantly below industry averages. Recent earnings have been mixed, with a beat in Q4 2025 but misses in Q1 and Q2 2026. Technical indicators show a bullish overall signal, though moving averages are bearish. Analyst consensus is positive with a 53.57% buy rating and a $16.17 price target, suggesting potential upside.
The outlook for VIPS is cautiously optimistic, driven by its attractive valuation and strong profitability metrics like a 24.44% ROE. However, risks include recent revenue declines and a challenging consumer environment in China. The stock's low multiples and positive cash flow from operations provide a margin of safety, but investors should monitor execution on future earnings and macroeconomic headwinds affecting consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
